Peritoneal metastases management: Towards the era of prospective randomized trials?

Vahan Kepenekian; Olivier Glehen

doi:10.1016/j.ejso.2020.05.011

Peritoneal metastases management: Towards the era of prospective randomized trials?

Eur J Surg Oncol. 2021 Jan;47(1):1-3. doi: 10.1016/j.ejso.2020.05.011. Epub 2020 Jun 15.

Authors

Vahan Kepenekian¹, Olivier Glehen²

Affiliations

¹ Service de Chirurgie Digestive et Endocrinienne, Hôpital Lyon Sud, Hospices Civils de Lyon, EMR 3738, Université Claude Bernard Lyon 1, Lyon, France. Electronic address: vahan.kepenekian@chu-lyon.fr.
² Service de Chirurgie Digestive et Endocrinienne, Hôpital Lyon Sud, Hospices Civils de Lyon, EMR 3738, Université Claude Bernard Lyon 1, Lyon, France.

PMID: 32576480
DOI: 10.1016/j.ejso.2020.05.011

No abstract available

Keywords: Colorectal peritoneal metastases; Cytoreductive surgery; HIPEC; PRODIGE7; PROPHYLO-CHIP; Peritoneal carcinomatosis; Peritoneal metastases.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Humans
Peritoneal Neoplasms / secondary*
Peritoneal Neoplasms / therapy*
Prospective Studies
Randomized Controlled Trials as Topic*